Insights

Innovative Biomaterials AMSilk's focus on creating high-performance silk-based biomaterials for industries such as textiles, biomedical, homecare, and automotive presents numerous sales opportunities for companies seeking sustainable and cutting-edge material solutions.

Strategic Collaborations Recent partnerships with industry leaders like Ajinomoto and Cargill highlight AMSilk's openness to collaboration, offering a pathway for potential joint ventures or supply chain integrations with firms specializing in fermentation, biotech, and sustainable materials.

Robust Funding Growth Securing over $60 million in strategic financing in 2025 and ongoing investments in Serie C indicate strong market confidence and financial stability, creating opportunities for upselling advanced material solutions or customized bioproducts to well-funded clients.

Sustainability Leadership AMSilk's pioneering use of bioengineered silk proteins aligns with increasing demand for eco-friendly products, making it an attractive partner for companies aiming to enhance their sustainable product offerings.

Technological Edge Utilizing advanced technologies like DNA editing and protein engineering positions AMSilk as a leader in biotech innovation, allowing sales teams to target forward-thinking companies interested in deploying next-generation biomaterials in their design and manufacturing processes.

Similar companies to AMSilk GmbH | Biotech Materials

AMSilk GmbH | Biotech Materials Tech Stack

AMSilk GmbH | Biotech Materials uses 8 technology products and services including DATEV, Adobe, Adobe InDesign, and more. Explore AMSilk GmbH | Biotech Materials's tech stack below.

  • DATEV
    Accounting And Finance
  • Adobe
    Audio, Video, Graphics
  • Adobe InDesign
    Cad & Graphics
  • SAP
    Customer Relationship Management
  • JSON-LD
    Javascript Frameworks
  • Lodash
    Javascript Libraries
  • PWA
    Miscellaneous
  • Personio
    Recruitment Marketing

Media & News

AMSilk GmbH | Biotech Materials's Email Address Formats

AMSilk GmbH | Biotech Materials uses at least 1 format(s):
AMSilk GmbH | Biotech Materials Email FormatsExamplePercentage
First.Last@amsilk.comJohn.Doe@amsilk.com
49%
First.MiddleLast@amsilk.comJohn.MichaelDoe@amsilk.com
1%
First.Last@amsilk.comJohn.Doe@amsilk.com
49%
First.MiddleLast@amsilk.comJohn.MichaelDoe@amsilk.com
1%

Frequently Asked Questions

Where is AMSilk GmbH | Biotech Materials's headquarters located?

Minus sign iconPlus sign icon
AMSilk GmbH | Biotech Materials's main headquarters is located at Anna-Sigmund Straße 1-3, Neuried, Bavaria 82061, DE. The company has employees across 2 continents, including EuropeNorth America.

What is AMSilk GmbH | Biotech Materials's official website and social media links?

Minus sign iconPlus sign icon
AMSilk GmbH | Biotech Materials's official website is amsilk.com and has social profiles on LinkedInCrunchbase.

What is AMSilk GmbH | Biotech Materials's SIC code NAICS code?

Minus sign iconPlus sign icon
AMSilk GmbH | Biotech Materials's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does AMSilk GmbH | Biotech Materials have currently?

Minus sign iconPlus sign icon
As of October 2025, AMSilk GmbH | Biotech Materials has approximately 79 employees across 2 continents, including EuropeNorth America. Key team members include Chief Scientific Officer: G. V.Chief Financial Officer: R. F.Chief Production Officer: K. K.. Explore AMSilk GmbH | Biotech Materials's employee directory with LeadIQ.

What industry does AMSilk GmbH | Biotech Materials belong to?

Minus sign iconPlus sign icon
AMSilk GmbH | Biotech Materials operates in the Biotechnology Research industry.

What technology does AMSilk GmbH | Biotech Materials use?

Minus sign iconPlus sign icon
AMSilk GmbH | Biotech Materials's tech stack includes DATEVAdobeAdobe InDesignSAPJSON-LDLodashPWAPersonio.

What is AMSilk GmbH | Biotech Materials's email format?

Minus sign iconPlus sign icon
AMSilk GmbH | Biotech Materials's email format typically follows the pattern of First.Last@amsilk.com. Find more AMSilk GmbH | Biotech Materials email formats with LeadIQ.

How much funding has AMSilk GmbH | Biotech Materials raised to date?

Minus sign iconPlus sign icon
As of October 2025, AMSilk GmbH | Biotech Materials has raised $35M in funding. The last funding round occurred on Sep 09, 2025 for $35M.

When was AMSilk GmbH | Biotech Materials founded?

Minus sign iconPlus sign icon
AMSilk GmbH | Biotech Materials was founded in 2008.
AMSilk GmbH | Biotech Materials

AMSilk GmbH | Biotech Materials

Biotechnology ResearchGermany51-200 Employees

AMSilk's Biogenius Materials made from silk proteins are setting new standards in material innovation. Using cutting-edge science and the most advanced technologies like DNA edition, protein engineering and precision fermentation, we transform biogenic materials inspired by nature into groundbreaking Biongenius Materials. At AMSilk, we turn man-made proteins into formulations, including fibers and yarns, hydrogels and silk powder. The high-performance qualities of our material enable a wide range of applications in the textile, homecare, biomedical, and automobile industries and bring breakthrough benefits for products and customers.

Section iconCompany Overview

Headquarters
Anna-Sigmund Straße 1-3, Neuried, Bavaria 82061, DE
Website
amsilk.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
51-200

Section iconFunding & Financials

  • $35M

    AMSilk GmbH | Biotech Materials has raised a total of $35M of funding over 6 rounds. Their latest funding round was raised on Sep 09, 2025 in the amount of $35M.

  • $1M$10M

    AMSilk GmbH | Biotech Materials's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $35M

    AMSilk GmbH | Biotech Materials has raised a total of $35M of funding over 6 rounds. Their latest funding round was raised on Sep 09, 2025 in the amount of $35M.

  • $1M$10M

    AMSilk GmbH | Biotech Materials's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.